FDA offers free, continuing education course to help health care providers understand biosimilars

Leah Christl, PhD, the Associate Director for Therapeutic Biologics at FDA, notes the agency has developed a free, continuing education course for health care professionals. The course, “FDA Overview of Biosimilar Products” is designed to help providers strengthen their knowledge and understanding of biosimilars and interchangeable products. The course also will help them understand how a biosimilar can be prescribed and dispensed, and how and when an interchangeable product can be substituted for another biological product.